Next Article in Journal
Chemical Compositions and Antioxidant Activities of Polysaccharides from the Sporophores and Cultured Products of Armillaria mellea
Next Article in Special Issue
Nitric Oxide Plays a Central Role in Water Stress-Induced Tanshinone Production in Salvia miltiorrhiza Hairy Roots
Previous Article in Journal
Nanoporous Materials as New Engineered Catalysts for the Synthesis of Green Fuels
Previous Article in Special Issue
Nitric Oxide Released from Luminal S-Nitroso-N-Acetylcysteine Increases Gastric Mucosal Blood Flow
Open AccessReview

Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis

1
Department of Pharmacy, "G. D'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
2
Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy
3
Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Via della Lastruccia 3, 50019 Sesto Fiorentino (Firenze), Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Claudio Battilocchio
Molecules 2015, 20(4), 5667-5679; https://doi.org/10.3390/molecules20045667
Received: 23 February 2015 / Revised: 15 March 2015 / Accepted: 24 March 2015 / Published: 31 March 2015
(This article belongs to the Special Issue Nitric Oxide (NO) Release Chemistry)
Due to the recognized biological role of nitric oxide (NO) donating derivatives and of selective inhibitors of specific human carbonic anhydrase isoforms (CA, EC 4.2.1.1), promising compounds having an aromatic/heterocyclic primary sulfonamide and functionalized with NO-releasing moieties have been designed. These bifunctional agents have been tested in vitro and in vivo to assess their dual pharmacological activity. According to the encouraging results they could be proposed for the treatment of angle-open glaucoma, cancer regression and osteoporosis, in which both NO and CA activities are involved. View Full-Text
Keywords: NO donors; selective carbonic anhydrase inhibitors; glaucoma; cancer; osteoporosis; dual pharmacological activity NO donors; selective carbonic anhydrase inhibitors; glaucoma; cancer; osteoporosis; dual pharmacological activity
Show Figures

Figure 1

MDPI and ACS Style

Carradori, S.; Mollica, A.; De Monte, C.; Granese, A.; Supuran, C.T. Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis. Molecules 2015, 20, 5667-5679. https://doi.org/10.3390/molecules20045667

AMA Style

Carradori S, Mollica A, De Monte C, Granese A, Supuran CT. Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis. Molecules. 2015; 20(4):5667-5679. https://doi.org/10.3390/molecules20045667

Chicago/Turabian Style

Carradori, Simone; Mollica, Adriano; De Monte, Celeste; Granese, Arianna; Supuran, Claudiu T. 2015. "Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis" Molecules 20, no. 4: 5667-5679. https://doi.org/10.3390/molecules20045667

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop